Si-bone, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SI-BONE, Inc. reported a 20.2% revenue increase to $200.9 million in 2025, driven by expanded product offerings and physician base, despite incurring a net loss of $18.9 million.
NASDAQ
SI-BONE, Inc.'s 10-K filing summarizes the company's FY2024 performance, strategic initiatives, and associated risks.
NASDAQ
SI-BONE, a medical device company, has entered into a new manufacturing agreement with RMS Company and filed its annual 10-K report, detailing its financial performance and strategic initiatives.